Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Compoundingaltro healthnfx503btelehealthglp-1

Altro Health raises $7m to white-label peptides and GLP-1s for gyms

The NFX-led seed round backs a platform that routes prescriptions through 503A and 503B pharmacies while gyms and med spas keep their own branding.

MH
By Maren Holt · Senior Reporter, GLP-1
Oct 7 08:39 ETSource: Health Tech World

The wire

  1. 01Altro Health closed a US$7m seed round led by NFX, with Founder Collective and Abby Miller Levy of Primetime Partners participating; more than 500 businesses use the platform, with plans from US$319 to US$599 a month.
  2. 02The model pushes peptides, GLP-1 medicines and hormone therapy into gyms and medical spas through 503A and 503B pharmacies, with Altro's clinical team supervising prescribing.
  3. 03Similar arrangements are spreading, including UFC Gym's venture with NexGen MD Scientific and Life Time's Miora clinics; oversight of fitness-channel prescribing remains an open regulatory question.

From the source

Altro Health secures US$7m to bring peptides and hormone therapy to wellness businesses

The company provides software that allows personal trainers, gyms and medical spas to offer services including peptides, GLP-1 medicines, hormone therapy and blood testing under their own brands.

Read at htworld.co.uk
PeptiPrescribed peptides from $99/moSee all →